Tucatinib,Trastuzumab,fulvestrant
Seagen
['melanoma', 'nsclc', 'ovarian', 'sclc']
hello #asco2023! learn more about our novel multi-targeted, enhanced engineered tcr-t #celltherapy product and phase 1 basket #clinicaltrial for #nsclc, #melanoma, #hncancer, #cervicalcancer #ovariancancer. today, 8-11am, hall a poster 396 (abstract 2554) 
Harnessing novel T cell systems to extend the promise of immunotherapy! #TScan #CellTherapy #UnleashImmunity